drugset / Trial / NCT07698938

The Safety and Microbial Changes in the Use of Intranasal Neosporin®

NCT07698938

NaSingle-groupOpen-labelBasic science

Summary

Neosporin is an over-the-counter, FDA-approved triple-antibiotic ointment. It is widely used to treat and prevent skin infections following minor burns and injuries. Although the Neosporin® prospect indicates its use is strictly topical, it is often used intranasally by ear, nose, and throat specialists, plastic surgeons, and intensivists to prevent and treat various conditions. Nonetheless, no literature has documented the safety of intranasal Neosporin®. We designed a prospective study to assess the safety of this intervention in healthy participants and to investigate microbial changes before and after the intervention. Healthy participants will apply Neosporin® intranasally for 15 days and record daily adverse events and their severity. Nasal cultures will be drawn before and after the intervention and compared.

Timeline

Start
2025-02-13
Primary completion
2025-03-22
Completion
2025-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacitracin zinc Unknown 40000 iu Intranasal
Subject Neomycin Unknown 0.35 g Intranasal
Subject Polymyxin B Peptide 500000 iu Intranasal

Indications

No indication recorded.